Showing results (1751-1760 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|September 2, 1999
In vitro activation of irinotecan to SN-38 by human liver and intestineF Ahmed, V Vyas, A Cornfield, et al.
Anticancer Research|September 2, 1999
CK20 gene expression: technical limits for the detection of circulating tumor cellsP Champelovier, F Mongelard, D Seigneurin
Anticancer Research|September 2, 1999
Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cellsD Thibout, M Kraemer, M Di Benedetto, et al.
Anticancer Research|September 2, 1999
Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferationE Ioachim, S Kamina, A Demou, et al.
Anticancer Research|September 2, 1999
TNM staging, histopathological grading, and tumor-associated antigens in patients with a history of mucoepidermoid carcinoma of the salivary glandsK Plambeck, R E Friedrich, M Bahlo, et al.
Anticancer Research|September 2, 1999
NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancerJ Briggman, R Genduso, C Camara, et al.
Anticancer Research|September 2, 1999
Differential tumor markers and hepatitis markers profile in liver tumorsA Khalifa, E A Mady, N Abadeer, et al.
Anticancer Research|September 2, 1999
p53 determination in gynecological carcinomas: immunohistochemistry compared to luminometric immunoassay (LIA)T Heinze, E Greiner-Mai, W Lichtenegger
Anticancer Research|September 2, 1999
Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumorsG Gebauer, M Rieger, W Jäger, et al.
Anticancer Research|September 2, 1999
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patientsA van Dalen, J Favier, L Baumgartner, et al.
Pageof 2,589